Literature DB >> 9234796

Colonization of congenitally immunodeficient mice with probiotic bacteria.

R D Wagner1, T Warner, L Roberts, J Farmer, E Balish.   

Abstract

We assessed the capacity of four probiotic bacteria (Lactobacillus acidophilus, Lactobacillus reuteri, Lactobacillus casei GG, and Bifidobacterium animalis) to colonize, infect, stimulate immune responses in, and affect the growth and survival of congenitally immunodeficient gnotobiotic beige-athymic (bg/bg-nu/nu) and beige-euthymic (bg/bg-nu/+) mice. The bacteria colonized and persisted, in pure culture, in the alimentary tracts of both mouse strains for the entire study period (12 weeks). Although all adult and neonatal beige-euthymic mice survived probiotic colonization, some infant mortality occurred in beige-athymic pups born to mothers colonized with pure cultures of L. reuteri or L. casei GG. The probiotic bacteria manifested different capacities to adhere to epithelial surfaces, disseminate to internal organs, affect the body weight of adult mice and the growth of neonatal mice, and stimulate immune responses. Although the probiotic species were innocuous for adults, these results suggest that caution and further studies to assess the safety of probiotic bacteria for immunodeficient hosts, especially neonates, are required.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9234796      PMCID: PMC175473          DOI: 10.1128/iai.65.8.3345-3351.1997

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  28 in total

Review 1.  Immune system stimulation by probiotics.

Authors:  G Perdigon; S Alvarez; M Rachid; G Agüero; N Gobbato
Journal:  J Dairy Sci       Date:  1995-07       Impact factor: 4.034

2.  On the safety of lactic acid bacteria from food.

Authors:  M R Adams; P Marteau
Journal:  Int J Food Microbiol       Date:  1995-10       Impact factor: 5.277

3.  Immunomodulation of the gnotobiotic mouse through colonization with lactic acid bacteria.

Authors:  H Link; F Rochat; K Y Saudan; E Schiffrin
Journal:  Adv Exp Med Biol       Date:  1995       Impact factor: 2.622

4.  B cell knockout mice are resistant to mucosal and systemic candidiasis of endogenous origin but susceptible to experimental systemic candidiasis.

Authors:  R D Wagner; A Vazquez-Torres; J Jones-Carson; T Warner; E Balish
Journal:  J Infect Dis       Date:  1996-09       Impact factor: 5.226

5.  Prophylactic effect of Enterococcus faecalis FK-23 preparation on experimental candidiasis in mice.

Authors:  K Satonaka; K Ohashi; T Nohmi; T Yamamoto; S Abe; K Uchida; H Yamaguchi
Journal:  Microbiol Immunol       Date:  1996       Impact factor: 1.955

6.  Commensal enteric bacteria engender a self-limiting humoral mucosal immune response while permanently colonizing the gut.

Authors:  K E Shroff; K Meslin; J J Cebra
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

7.  Lactobacilli and bacteremia in southern Finland, 1989-1992.

Authors:  M Saxelin; N H Chuang; B Chassy; H Rautelin; P H Mäkelä; S Salminen; S L Gorbach
Journal:  Clin Infect Dis       Date:  1996-03       Impact factor: 9.079

8.  Translocation of certain indigenous bacteria from the gastrointestinal tract to the mesenteric lymph nodes and other organs in a gnotobiotic mouse model.

Authors:  R D Berg; A W Garlington
Journal:  Infect Immun       Date:  1979-02       Impact factor: 3.441

9.  The induction of cardioangitis by Lactobacillus casei cell wall in mice. I. The cytokine production from murine macrophages by Lactobacillus casei cell wall extract.

Authors:  S Okitsu-Negishi; I Nakano; K Suzuki; S Hashira; T Abe; K Yoshino
Journal:  Clin Immunol Immunopathol       Date:  1996-01

10.  Passive protection against rotavirus-induced diarrhea of mouse pups born to and nursed by dams fed Bifidobacterium breve YIT4064.

Authors:  H Yasui; J Kiyoshima; H Ushijima
Journal:  J Infect Dis       Date:  1995-08       Impact factor: 5.226

View more
  13 in total

1.  Biotherapeutic effects of probiotic bacteria on candidiasis in immunodeficient mice.

Authors:  R D Wagner; C Pierson; T Warner; M Dohnalek; J Farmer; L Roberts; M Hilty; E Balish
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

2.  The use of probiotics in the prevention of necrotizing enterocolitis in preterm infants.

Authors:  Nicole Ladd; Tiffany Ngo
Journal:  Proc (Bayl Univ Med Cent)       Date:  2009-07

3.  Enhanced clearance of Candida albicans from the oral cavities of mice following oral administration of Lactobacillus acidophilus.

Authors:  S Elahi; G Pang; R Ashman; R Clancy
Journal:  Clin Exp Immunol       Date:  2005-07       Impact factor: 4.330

4.  Lactobacilli from human gastrointestinal mucosa are strong stimulators of IL-12 production.

Authors:  C Hessle; L A Hanson; A E Wold
Journal:  Clin Exp Immunol       Date:  1999-05       Impact factor: 4.330

5.  Neonatal Necrotizing Enterocolitis -Inflammation and Intestinal Immaturity.

Authors:  Erika C Claud
Journal:  Antiinflamm Antiallergy Agents Med Chem       Date:  2009-09

Review 6.  Probiotics for preterm infants?

Authors:  M Millar; M Wilks; K Costeloe
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2003-09       Impact factor: 5.747

Review 7.  Microbial therapeutic interventions.

Authors:  Nicole G Grady; Elaine O Petrof; Erika C Claud
Journal:  Semin Fetal Neonatal Med       Date:  2016-04-25       Impact factor: 3.926

8.  Genotypic and phenotypic studies of murine intestinal lactobacilli: species differences in mice with and without colitis.

Authors:  J A Peña; S Y Li; P H Wilson; S A Thibodeau; A J Szary; J Versalovic
Journal:  Appl Environ Microbiol       Date:  2004-01       Impact factor: 4.792

9.  Live probiotics protect intestinal epithelial cells from the effects of infection with enteroinvasive Escherichia coli (EIEC).

Authors:  S Resta-Lenert; K E Barrett
Journal:  Gut       Date:  2003-07       Impact factor: 23.059

Review 10.  Do children's upper respiratory tract infections benefit from probiotics?

Authors:  Susanna Esposito; Donato Rigante; Nicola Principi
Journal:  BMC Infect Dis       Date:  2014-04-10       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.